Paloma Partners’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Paloma Partners’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-10,239	Closed	-$989K	–	2676
2020 Q2	$989K	Buy	+10,239	New	+$854K	0.02%	925
2020 Q1	–	Sell	-3,146	Closed	-$230K	–	2352
2019 Q4	$230K	Sell	3,146 -2,055	-40%	-$125K	﹤0.01%	1912
2019 Q3	$271K	Buy	+5,201	New	+$277K	0.01%	1588
2019 Q2	–	Sell	-4,317	Closed	-$225K	–	2341
2019 Q1	$225K	Buy	+4,317	New	+$199K	0.01%	1456
2018 Q1	–	Sell	-7,009	Closed	-$294K	–	2377
2017 Q4	$294K	Buy	+7,009	New	+$270K	﹤0.01%	1567

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Paloma Partners's MYOK Position: Q3 2020 in Review

Paloma Partners sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 10,239 shares — an estimated $989K sold.

Paloma Partners first reported a position in MYOK in Q4 2017 and held it in 5 quarters. The position peaked at $989K in Q2 2020. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

Paloma Partners reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Paloma Partners sold 10,239 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $989K.
Paloma Partners first reported a position in MyoKardia, Inc. Common Stock in Q4 2017 and held it in 5 quarters.
Paloma Partners's MyoKardia, Inc. Common Stock position peaked at $989K in Q2 2020.
237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Paloma Partners's 13F filing for Q3 2020, filed 16 Nov 2020.